[1]
Sadikova N.G, Najmutdinova D. K, Urunbayeva D. A, Alimova S. E, and Tillaboyev Sh.Sh, “Sglt-2 Inhibitors in Diabetic Type 2 Patients Nephroprotective Effects of (Empagliflozin)”, Gen. Rep., vol. 26, pp. 1–4, Nov. 2023.